DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

170.10 0.26 (0.15%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

JAZZ $170.10 0.15%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $172.17
Previous Close $169.84
Daily Range $169.47 - $173.38
52-Week Range $108.58 - $180.00
Market Cap $10.3B
P/E Ratio 339.68
Dividend (Yield) $0.00 (0.0%)
Volume 559,529
Average Daily Volume 687,960
Current FY EPS $7.58





Jazz Pharmaceuticals, Inc. (JAZZ) Description

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Website:

News & Commentary Rss Feed

Should You Invest in Corporate Tax Inversions?

Despite the controversy regarding whether corporate inversions are right or wrong, investors are looking to make money from them. Has Motif Investing put together a way for small investors to profit from tax inversions?

Riding The Bull Market With These 2 Momentum ETFs

Insider Trading Alert - JAZZ, SSS And PLKI Traded By Insiders

Growth Momentum Should Continue For This Pharmaceutical Company

Is Jazz Pharmaceuticals (JAZZ) a Great Growth Stock? - Tale of the Tape

Sucampo-Takeda Sue Dr. Reddy's for Amitiza Patent Violation - Analyst Blog

Update: Jazz Pharmaceuticals Q3 Earnings

2 Biotech Stocks to Buy After Earnings

Why eBay is like a divorcee, and a pharma pick that’s setting up for a pop

3 Stocks Moving The Drugs Industry Upward

Jazz Pharmaceuticals (JAZZ) Downgraded From Buy to Hold

See More JAZZ News...

JAZZ's Top Competitors

JAZZ $170.10 (0.15%)
Current stock: JAZZ
JNJ $107.86 (0.35%)
Current stock: JNJ
NVS $94.98 (-0.30%)
Current stock: NVS
RHHBY $37.33 (-0.93%)
Current stock: RHHBY